Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Ardagh Metal Packaging S.A. - First Quarter 2025 Results
-
TriCo Bancshares Reports First Quarter 2025 Net Income of $26.4 Million, Diluted EPS of $0.80
-
Ardagh Metal Packaging S.A. Declares Quarterly Dividend
-
Popular School Safety Platform Expands To Manage Student AI Use In K-12 Classrooms
-
10% Rebate: Bybit Card Introduces USDC Cashback
-
OLD REPUBLIC REPORTS RESULTS FOR THE FIRST QUARTER 2025
-
OneDigital Financial Selects Broadridge Technology to Grow Retirement Practice and Enhance Advisor Efficiency
-
SMOOTHIE KING DRIVES CONSISTENT GROWTH MOMENTUM IN Q1 WITH 13 STORE OPENINGS AND 20 NEW STORE COMMITMENTS
-
Ameriprise Financial Reports First Quarter 2025 Results
-
First BanCorp. Announces Earnings for the Quarter Ended March 31, 2025
-
Core Natural Resources to Announce First Quarter 2025 Results on May 8
-
Enbridge Inc. Declares Quarterly Dividends
-
EmpiRx Health Partners with Giant Eagle to Transform Pharmacy Benefits Care
-
ActiveState Empowers Data Scientists with R Language Support, Strengthening Leadership in Open Source Security Posture Management
-
Stallion Uranium Closes $1.45 million Private Placement
-
AMERICAN FORK - Clifton Mining Company (OTCBB: CFTN) (Clifton) - "Production Startup"
-
Catalyst Bancorp, Inc. Announces 2025 First Quarter Results
-
Insmed Announces Redemption of all $569.5 Million of Remaining Outstanding 0.75% Convertible Senior Notes Due 2028
-
Texas Offers Tax Break on Emergency Essentials April 26-28 Propane Council Highlights Key Preparedness Items Like Generators, Detectors
-
P&G Announces Fiscal Year 2025 Third Quarter Results
-
Amwins Launches CoverCap Program
-
LSI Industries Reports Fiscal 2025 Third Quarter Results and Declares Quarterly Cash Dividend
-
Comcast Reports 1st Quarter 2025 Results
-
Corero Named Finalist for the 2025 Joseph C. Belden Innovation Award
-
Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
-
Mobileye Releases First Quarter 2025 Results and Reaffirms Full-Year Outlook
-
World Chess and the Algorand Foundation propose leveling the playing field with a "chess passport"
-
Digital Realty Deploys Three Microsoft Azure ExpressRoute Cloud On-Ramps
-
Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision
-
Profit During Inflation with ezPaycheck by Processing Payroll for Employee & Contractors, In-House
-
Camunda Announces Publication of New Enterprise Process Orchestration Book
-
Kymera Therapeutics to Unveil New Oral Immunology Program and Report First Quarter 2025 Financial Results on May 9, 2025
-
Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep's Tumor-Fighting Mechanism of Action
-
Aeva Announces Date for First Quarter 2025 Results and Conference Call
-
Universal Electronics Inc. to Host First Quarter 2025 Financial Results Conference Call on May 8th
-
IntellaTriage Names Cassidy Abkes, RN 2024 Nurse of the Year Based on Exceptional Performance
-
Cultivarium to Develop Advanced Tools for Fungi and Archaea
-
Checkmarx One Breaks the AppSec Barrier by Delivering ASPM Directly to Developers
-
Kaira Technologies announces PEAK Capital Partners' major investment: a game-changer in the financial services industry
-
Hecla Announces First Quarter 2025 Earnings Call
-
TelevisaUnivision Announces First Quarter 2025 Results
-
Bausch + Lomb Returning enVista® Intraocular Lenses to Market Following Voluntary Recall
-
D-Wave Quantum to Report First Quarter Fiscal Year 2025 Financial Results on May 8, 2025
-
Identiv Partners with Tag-N-Trac to Market IoT Solutions for Cold Chain Tracking and Compliance
-
Seaport Therapeutics Presents New Preclinical Data on SPT-320 (Glyph Agomelatine) at the Society of Biological Psychiatry (SOBP) Annual Meeting
-
Novocure Reports First Quarter 2025 Financial Results
-
Independent Directors of Phillips 66 Issue Letter to Investors and Their Stewardship Teams
-
Ardagh Group S.A. First Quarter 2025 Adjusted EBITDA Rises 14% to $290 million
-
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test
-
Energy Recovery to Release First Quarter 2025 Financial Results

